Abstract
The rat is a widely used model in biomedical research and is often the preferred rodent model in many areas of physiological and pathobiological research. Although many genetic tools are available for the rat, methods to produce gene-disrupted knockout rats are greatly needed. In this study, we developed protocols for creating N-ethyl-N-nitrosourea (ENU)-induced germline mutations in several rat strains. F1 preweanling pups from mutagenized Sprague Dawley (SD) male rats were then screened for functional mutations in Brca1 and Brca2 using a yeast gap-repair, ADE2-reporter truncation assay. We produced knockout rats for each of these two breast cancer suppressor genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jacob, H.J. & Kwitek, A.E. Rat genetics: attaching physiology and pharmacology to the genome. Nat. Rev. Genet. 3, 33–42 (2002).
Justice, M.J., Noveroske, J.K., Weber, J.S., Zheng, B. & Bradley, A. Mouse ENU mutagenesis. Hum. Mol. Genet. 8, 1955–1963 (1999).
Noveroske, J.K., Weber, J.S. & Justice, M.J. The mutagenic action of N-ethyl-N-nitrosourea in the mouse. Mamm. Genome 11, 478–483 (2000).
Russell, W.L. et al. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc. Natl. Acad. Sci. USA 76, 5918–5922 (1979).
Beier, D.R. Sequence-based analysis of mutagenized mice. Mamm. Genome 11, 594–597 (2000).
Justice, M.J. et al. Effects of ENU dosage on mouse strains. Mamm. Genome 11, 484–488 (2000).
Ishioka, C. et al. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat. Genet. 5, 124–129 (1993).
Kataoka, A. et al. Development of a yeast stop codon assay readily and generally applicable to human genes. Am. J. Pathol. 159, 1239–1245 (2001).
Culbertson, M.R. RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet. 15, 74–80 (1999).
Frischmeyer, P.A. & Dietz, H.C. Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 8, 1893–1900 (1999).
Kuramoto, T., Nomoto, T., Sugimura, T. & Ushijima, T. Cloning of the rat agouti gene and identification of the rat nonagouti mutation. Mamm. Genome 12, 469–471 (2001).
Suzuki, A. et al. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11, 1242–1252 (1997).
Connor, F. et al. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17, 423–430 (1997).
Freidman, L.S. et al. Thymic lymphomas in mice with a truncating mutation in Brca2. Cancer Res. 58, 1338–1343 (1998).
Flaman, J.-M. et al. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. Natl. Acad. Sci. USA 92, 3963–3967 (1995).
Andreutti-Zaugg, C., Scott, R.J. & Iggo, R. Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques. Cancer Res. 57, 3288–3293 (1997).
Nakatsukasa, E. et al. Generation of live rat offspring by intrauterine insemination with epididymal spermatozoa cryopreserved at −196 °C. Reproduction 122, 463–467 (2001).
Nakagata, N. Cryopreservation of mouse spermatozoa. Mamm. Genome 11, 572–576 (2000).
Coghill, E.L. et al. A gene-driven approach to the identification of ENU mutants in the mouse. Nat. Genet. 30, 255–256 (2002).
Yamamoto, K. et al. A functional and quantitative mutational analysis of p53 mutations in yeast indicates strand biases and different roles of mutations in DMBA- and BBN-induced tumors in rats. Int. J. Cancer 83, 700–705 (1999).
Acknowledgements
We thank Amy Moser for discussions and suggestions during the course of this work; R. Iggo, M. Tada, and T. Moriuchi for providing the pLSRP53 plasmid and the yIG397 yeast strain used in this paper; Henry Pitot for analysis of the histology sections; and Dinelli M. Monson and Millicent A. Shultz for technical assistance. This work has been supported by grants from the US National Institutes of Health (CA28954 and CA77494).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Zan, Y., Haag, J., Chen, KS. et al. Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat Biotechnol 21, 645–651 (2003). https://doi.org/10.1038/nbt830
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt830
This article is cited by
-
Application of genome editing technologies in rats for human disease models
Journal of Human Genetics (2018)
-
Generation of genetically-engineered animals using engineered endonucleases
Archives of Pharmacal Research (2018)
-
From engineering to editing the rat genome
Mammalian Genome (2017)
-
Efficient Production of Fluorescent Transgenic Rats using the piggyBac Transposon
Scientific Reports (2016)
-
CRISPR/Cas-mediated genome editing in the rat via direct injection of one-cell embryos
Nature Protocols (2014)